Espinoza Octavio bought LGND

December 16, 2025 · Form 4 insider transaction

Espinoza Octavio bought 181 shares of Ligand Pharmaceuticals Incorporated at $103.42 per share, a transaction worth $18.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
181
Price
$103.42
Total value
$18.7K
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after28,567
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR